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Purpose: Manitoba Oculotrichoanal (MOTA) syndrome is an autosomal recessive disorder present in First Nations
families that is characterized by ocular (cryptophthalmos), facial, and genital anomalies. At the commencement of this
study, its genetic basis was undefined.
Methods: Homozygosity analysis was employed to map the causative locus using DNA samples from four probands of
Cree ancestry. After single nucleotide polymorphism (SNP) genotyping, data were analyzed and exported to PLINK to
identify regions identical by descent (IBD) and common to the probands. Candidate genes within and adjacent to the IBD
interval were sequenced to identify pathogenic variants, with analyses of potential deletions or duplications undertaken
using the B-allele frequency and log2 ratio of SNP signal intensity.
Results: Although no shared IBD region >1 Mb was evident on preliminary analysis, adjusting the criteria to permit the
detection of smaller homozygous IBD regions revealed one 330 Kb segment on chromosome 9p22.3 present in all 4
probands. This interval comprising 152 SNPs, lies 16 Kb downstream of FRAS1-related extracellular matrix protein 1
(FREM1), and no copy number variations were detected either in the IBD region or FREM1. Subsequent sequencing of
both genes in the IBD region, followed by FREM1, did not reveal any mutations.
Conclusions: This study illustrates the utility of studying geographically isolated populations to identify genomic regions
responsible for disease through analysis of small numbers of affected individuals. The location of the IBD region 16 kb
from FREM1 suggests the phenotype in these patients is attributable to a variant outside of FREM1, potentially in a
regulatory element, whose identification may prove tractable to next generation sequencing. In the context of recent
identification of FREM1 coding mutations in a proportion of MOTA cases, characterization of such additional variants
offers scope both to enhance understanding of FREM1’s role in cranio-facial biology and may facilitate genetic counselling
in populations with high prevalences of MOTA to reduce the incidence of this disorder.
Manitoba Oculotrichoanal (MOTA) syndrome is a rare
autosomal recessive disorder, first documented in the Island
Lake region of Northern Manitoba [1]. Individuals of native
Aboriginal  descent  (Canada’s  First  Nations  peoples)
exhibited ocular anomalies, most notably a fusion of the upper
eyelid to the globe, known as subtotal cryptophthalmos or
hidden eye. Associated phenotypes included facial anomalies
with  aberrant  hair  distribution  extending  below  the  brow,
nasal dimpling, as well as ano-genital anomalies [2]. The
existence  of  a  similar  disorder  in  the  Inuit  [3],  who  are
ancestrally related to the First Nations, suggested a common
genetic etiology. MOTA syndrome is phenotypically similar
to Fraser Syndrome (FS), with common features including
cryptophthalmos, nasal and genital anomalies [4]; however
MOTA  probands  are  less  severely  affected  and  to  our
knowledge do not exhibit cognitive impairment, syndactyly,
renal, auricular, or limb defects.
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Both disorders are autosomal recessively inherited [2].
Fraser syndrome cases are attributable to mutations in either
FRAS1  (Fraser  syndrome  1)  or  FREM2  (FRAS1-related
extracellular  matrix  protein  2)  [5-7],  with  these  genes
accounting for approximately 40% of cases. Other FRAS/
FREM gene family members (FREM1 and FREM3) form
multi-protein  complexes  in  the  extracellular  matrix  that
interact with GRIP1, (glutamate receptor-interacting protein
1) which serves to anchor FRAS/FREM proteins [8,9], and in
which mutations were recently detected in FS probands [10].
Linkage  analysis  of  Fraser  Syndrome  to  the  vicinity  of
FREM1  (chromosome  9p22.3)  was  reported  5  years  ago,
however no disease causing mutations were identified [11].
More recently, homozygous FREM1 mutations were shown
in a Middle Eastern sibship [12] to be associated with a bifid
nose,  anorectal,  and  renal  anomaly  phenotype,  but  which
lacked  cryptophthalmos,  suggesting  that  FRAS/FREM
variants  may  contribute  to  a  diverse  spectrum  of  related
disorders [13].
The Fras/Frem, and Grip1 genes have been extensively
studied in murine models, strains, collectively referred to as
“bleb” mutants due to epidermal blistering during embryonic
development  [14-17].  These  exhibit  cryptophthalmos,
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1301syndactyly  and  renal  defects  that  correspond  with  those
phenotypes observed in FS patients. Fras/Frem genes, which
are expressed in a tissue specific manner and encode proteins
that are secreted into the extracellular matrix, regulate the
bioavailability of growth factors during development [18] and
so have key roles in tissue morphogenesis [19,20]. FRAS/
FREM  proteins  contain  chondroitin  sulfate  proteoglycan
(CSPG)  domains,  and  their  tissue  specific  expression  is
thought to maintain epithelial-mesenchymal integrity during
development via a mechanism similar to CSPG4 (or NG2),
directly binding collagens V and VI as well as fibroblast
growth  factor  (FGF)  and  epidermal  growth  factor  (EGF)
[21,22].
At the commencement of this study MOTA syndrome
was  molecularly  undefined,  with  no  FRAS/FREM  family
members known to underlie MOTA. We used homozygosity
mapping,  an  approach  that  permits  mapping  of  genes
responsible for autosomal recessive disorders [23-26]. Single
nucleotide  polymorphisms  (SNPs)  were  used  to  identify
regions  that  are  Identical  By  Descent  (IBD)  in  multiple
affected individuals and so determine the genomic interval
responsible  for  disease  [27,28].  This  methodology  takes
advantage of the geographically isolated nature of the First
Nations  community  studied  and  MOTA’s  reported
inheritance  pattern,  enabling  the  molecular  basis  to  be
elucidated using a very small number of patient samples.
METHODS
Patients and genomic DNA collection: Affected individuals
were derived from three pedigrees of Cree ancestry living in
a geographically isolated region in Northern Alberta (Figure
1). Since the area is only accessible during the winter by ice
roads,  this  was  anticipated  to  result  in  high  levels  of
consanguinity in the approximately 1,000 inhabitants. Blood
samples were collected from four probands (1.III-1, 2.V-2,
3.III-1, and 3.III-7) and the unaffected parent (mother) that
accompanied  each  child  for  oculoplastic  surgery  at  the
regional  ophthalmic  center,  followed  by  genomic  DNA
extraction. Ethical approval was provided by the University
of  Alberta  Hospital  Health  Research  Ethics  Board,  and
informed consent was obtained from all participants.
Genotyping  and  homozygosity  mapping:  Genotyping  was
performed using a 610-Quad SNP array (Illumina Inc., San
Diego, CA) comprising approximately 28,000 Copy Number
Variant  (CNV)  probes  and  592,000  single  nucleotide
polymorphisms (SNPs), spaced at a mean distance of 1 SNP
per 2.7 kb across the genome, and processed by deCODE
genetics in Reykjavík, Iceland. Raw data were analyzed using
GenomeStudio  software  (Illumina),  non-Mendelian
genotypes removed using the software’s Heritability Report
algorithm,  and  then  exported  to  PLINK  v1.07  for
homozygosity analysis [29]. Homozygous regions were then
analyzed  to  define  IBD  intervals  common  among  the
probands.  Initial  homozygosity  analysis  performed  using
default PLINK parameters (homozygous region >1 Mb) did
not identify an IBD interval common to all four probands.
Subsequently,  criteria  were  altered  to  permit  detection  of
smaller homozygous segments (>300 kb) comprising at least
100  consecutive  homozygous  SNPs.  In  addition  the
percentage  homozygosity  of  each  genome  was  calculated
using the total length of homozygous regions >300 kb divided
by that of the autosomes (NCBI Build 36) [30].
SNP visualization of genotype and CNV status: Two values
were calculated from the array data to determine if any copy
number variants were present. The first (B-Allele Frequency
[BAF])  is  derived  from  the  relative  ratio  of  fluorescent
intensities of the two alleles at each SNP (Cy5 [green] A allele;
Cy3 [red] B allele) with a heterozygous SNP having a BAF
of 0.5, while homozygous SNPs are either 1 or 0. The second
criterion used, is the logarithm of the ratio of the observed to
the expected intensities at each SNP (Log2R ratio [LRR]), with
deviations from zero (log21) providing evidence of a CNV
(deletion=-1,  duplication=0.5,  normal=0).  Additional
software (CnvPartition 3.1.6; Illumina) was used in parallel
with LRR data to assign a CNV value for each SNP, and so
detect any potential deletions or duplications.
Candidate gene sequencing: The coding and splice junctions
of three genes lying in or adjacent to the genomic region of
interest (FREM1, cerberus 1 (CER1) [31], and zinc finger,
DHHC-type containing 21 (ZDHHC21) [32]) were sequenced
using published primers [12] or those designed with Primer3
(Appendix  1).  Genomic  DNA  from  a  single  affected
individual (1.III-1) was used as template and sequence data
generated (ABI Prism 3100, Applied Biosystems, Foster City,
CA)  was  analyzed  relative  to  the  ENSEMBL  reference
sequence (Sequencher 4.6; GeneCodes, Madison, WI).
Evolutionary  conserved  regions  (ECRs)  within  the  IBD
region: In an effort to identify potential regulatory elements
within  the  IBD  interval,  non-coding  genomic  sequences
conserved in vertebrates were defined using ECR Browser
[33], with appropriate correction for the different genomic
builds (SNP array, Build 36, ECR Brower, Build 37) using the
UCSC LiftOver tool [30]. Criteria consisted of ECRs with a
minimum length of 90 bp and greater than 70% conservation
of the human sequence against chimpanzee, rhesus monkey,
cow, dog, opossum, rat, mouse, chicken, frog, pufferfish, or
zebrafish  genomes.  ECRs  conserved  between  human  and
Xenopus  (Table  1)  were  selected  for  further  analysis  and
sequenced with primers designed by Primer 3 (Appendix 2).
RESULTS
Phenotypic  analysis:  The  four  MOTA  cases  displayed  a
spectrum of ocular anomalies with considerable variation in
phenotypic  severity.  There  was  a  greater  proportion  of
bilateral (n=3) than unilateral involvement (Figure 2), and
cases with partial upper eyelid involvement most frequently
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1302affected the medial segment. Additional features included
fusion of the eyelid to the cornea, which ranged in severity
from total fusion (Figure 2D) to focal synechiae (Figure 2E,F),
as  well  as  frequent  corneal  opacification  and  corneal
vascularisation (Figure 2G,H). Aberrant facial development
was evident from extension of hair distribution from the scalp
to reach the eyebrow (Figure 2B,C) as well as nasal dimpling
(Figure 2B,D).
Molecular analyses: Only a small number of SNPs (67 – 95
[~0.01%]; Appendix 3) were excluded due to non-Mendelian
Figure 1. The three MOTA pedigrees exhibit an inheritance pattern compatible with autosomal recessive disease. Asterisks denote individuals
that provided blood samples.
Molecular Vision 2012; 18:1301-1311 <http://www.molvis.org/molvis/v18/a137> © 2012 Molecular Vision
1303errors,  indicating  that  the  genotyping  data  were  of  high
quality. High homozygosity levels were observed in the four
affected  individuals  (range:  9.3%  –  15.8%;  Appendix  4),
indicating  very  substantial  degrees  of  consanguinity  that
contrast  with  the  ~6%  theoretically  calculated  for  the
offspring of a first cousin marriage [34,35]. Homozygosity
mapping  analysis  identified  only  a  single  segment  that  is
identical by descent in the four affected individuals. This
330kb interval on 9p22.3 (Chr.9: 14,377,817 - 14,711,766,
flanking SNPs rs2382470 and rs1494359) lies approximately
16 kb 3′ to the last exon of FREM1 and the SNPs in this IBD
interval  display  BAF  values  of  1  or  0  in  the  probands
(demonstrating homozygosity) while the unaffected parents
are  heterozygous  (BAF=~0.5)  (Figure  3A;  upper  panels).
Equally, the LRR values cluster around zero for the 152 SNPs
in the IBD region, demonstrating the absence of any CNVs
(Figure  3A;  lower  panels).  In  particular,  the  SNPs
encompassing  FREM1  (9:  14,727,151  -  14,900,234)  have
normal LRR values and additional automated CNV analysis
(CnvPartition) demonstrated that no CNVs were detectable in
either the IBD (data not shown) or FREM1 intervals (Figure
3B).  Similarly,  no  CNVs  or  additional  IBD  regions  were
detected  in  the  intervals  encompassing  FRAS1,  FREM2,
FREM3, or GRIP1 (data not shown).
The  IBD  region  contains  two  genes  CER1  (a  TGF-β
signaling antagonist) [31] and ZDHCC21 (a regulator of hair
follicle development) [32] and as illustrated (Figure 4) its
border  is  distinct  from  that  of  FREM1.  Sequencing  was
performed initially for CER1 and ZDHCC21, with no coding
or  splice  site  mutations  identified.  Notwithstanding  the
homozygosity mapping data, the 38 exons of FREM1 were
next sequenced and did not identify any causative variants.
Ten homozygous variants were present: seven that result in
synonymous amino acid substitutions, one non-synonymous
SNP  (A1212S)  present  in  28%  of  controls  (dbSNP
rs35870000), and a 5′UTR variant (Table 2). Notably a variant
(c.5556A>G) that was recently described as contributing to
MOTA  [35],  did  not  segregate  in  an  autosomal  recessive
pattern (homozygous 1.III-1; heterozygous 3.III-1 and 3.III-7;
homozygous  wildtype  2.V-2).  Seven  non-coding  regions
within  the  IBD  interval  were  found  to  be  evolutionarily
conserved  with  >70%  identity  between  humans  and
Xenopus.  Sequencing  these  seven  regions  identified  a
homozygous T>C base pair substitution that segregated with
the disease phenotype (all probands: C/C, unaffected parents
T/C; Appendix 5).
DISCUSSION
This study’s key finding is the identification of a 330 kb region
on  chromosome  9p22.3  that  is  associated  with  MOTA
syndrome.  This  illustrates  the  value  of  studying
consanguineous populations such as the First Nations with
homozygosity analysis. These findings localize the causative
variant to an interval adjacent to FREM1, which represents an
excellent candidate on the basis of the recapitulation of the
human phenotypes in Frem1 mutant mice [36,37], and related
phenotypes induced by mutation of other FRAS/FREM gene
family members. This study was predicated on the assumption
that the level of homozygosity in a geographically isolated
population, living on a remote reserve, would be increased.
The  range  of  autosomal  homozygosity  observed  (9.3%  -
15.8%), which in some cases exceeds that observed in other
consanguineous populations or in the offspring of first cousin
marriages [34], validates the approach used and contrasts with
the far lower rates observed in a general population (1.9% -
4.6%) [38]. These data, derived from a very small number of
affected  individuals,  illustrate  the  applicability  of
homozygosity mapping in the First Nations and suggest that
it  may  permit  other  causes  of  this  population’s
disproportionately large disease burden to be identified.
While this manuscript was in preparation, two papers
were published that substantially advanced understanding of
FREM1’s role in these disorders [13,35]. The first, reported
several FREM1 mutations in MOTA cases of either First
Nations  or  European  ancestry  [35]  including:  an  inframe
deletion of exons 8–23, one nonsense, two missense, and a
synonymous alteration (c.5556A>G). Notably, neither of the
two variants identified in First Nations patients (deletion of
exons 8 – 23 or c.5556A>G [G1853G]) is the cause in our
cases, in view of the absence of CNVs in the 330 kb region
(Figure 3) and the fact that c.5556A>G’s does not segregate
with disease (data not shown). Since a second causative allele
was not identified in some individuals of Oji-Cree ancestry
reported in Slavotinek et al. [35], the possibility therefore
TABLE 1. CONSERVED REGIONS IDENTIFIED WITHIN THE 330 KB IBD REGION.
ECR Genomic position Length (bp) % identity
1 14423929–14424022 94 89%
2 14443290–14443585 296 80%
3 14520772–14520883 112 71%
4 14521314–14521641 328 74%
5 14521719–14522534 816 78%
6 14522575–14522705 131 72%
7 14549013–14549211 199 71%
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1304Figure 2. MOTA phenotypic spectrum in Albertan First Nations pedigrees. The oculo-facial phenotypes observed are diverse, ranging from
isolated ocular anomalies to broader characteristics including dimpled noses (white arrows) and aberrant hair wedges where hair extends
across the forehead to reach the eyebrow (black arrows). As evident from the montage, the ocular malformations can be bilateral (A, B) or
unilateral (C, D), and vary in terms of the degree of lid involvement from isolated fusion (D) to abortive cryptophthalmos (E). Associated
features include corneopalpebral synechiae (E, F), corneal opacification (G), and vascularization (H).
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1305Figure 3. Montage illustrating representative genotype and copy number data across the IBD interval and FREM1. A: Genotype status (upper
panels) and copy number data (lower panels) are provided for the first 55 SNPs in the IBD region (Chr9: 14,377,817–14,484,388). The BAF
plots demonstrate homozygosity in the probands (BAF=1 or 0) and heterozygosity in the unaffected parents (BAF=0.5). The LRR plots also
suggest no CNVs are present (LRR ~0). B: The lack of CNVs in FREM1 (14,727,151–14,900,234) is evident from LRR plots. CnvPartition
did not detect any CNVs in this region as all 96 SNPs in this region were assigned a normal CNV value of 2.
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1306exists that a still to be identified allele is common to both the
Oji-Cree  and  First  Nations  populations.  The  second
publication describes heterozygous FREM1 deletions and 3
missense  variants  that  associate  with  metopic
craniosynostosis as well as documenting the contribution of
FREM1  in  patterning  the  murine  cranial  skeleton  [13].
Accordingly  our  study  demonstrates  additional  genetic
heterogeneity among the First Nations, who would have been
anticipated to have a single cause for the phenotype.
The most parsimonious explanation for our findings is
that a sequence variant within the 330 kb IBD interval, which
is located 16 kb 3′ of FREM1’s last known exon, causes
MOTA. This is most likely to represent a regulatory element;
however the possibility that an additional exon remains to be
defined, cannot be excluded. Support for the concept of a
regulatory variant is provided by the Frem1bfd murine strain,
which lacks a coding Frem1 mutation and is believed to have
a variant in a control region that causes cryptophthalmos-like
phenotypes [37]. Frem1’s role during development suggests
that its temporal-spatial expression is tightly controlled, in
keeping  with  the  regulatory  elements  and  tissue  specific
enhancers  defined  for  a  range  of  other  developmental
regulatory genes [39]. There are several examples of such
mutated sequences in both ocular and systemic diseases, with
Figure 4. Illustration of the homozygous regions and the IBD interval in the four probands. The regions of homozygosity, which range from
330 kb to 10.4 Mb, include a 330 kb IBD interval common to all probands (red line). This interval contains ZDHHC21 and CER1, and is 16
kb 3′ of FREM1’s last exon. Homozygosity mapping defined one IBD interval suggesting that mutation responsible for MOTA lies within
the narrow 330 kb region.
TABLE 2. SEQUENCE VARIANTS IDENTIFIED.
Gene Exon Variant Amino acid residue dbSNP reference
number
ZDHHC21 exon 6 c.318 T>C C106C rs17215796
FREM1 exon 3 c.-135C>G N/A  
  exon 5 c.456 A>G Q152Q rs10961757
  exon 21 c.3634 G>T A1212S rs35870000
  exon 26 c.4785 C>T A1595A rs10733289
  exon 26 c.4791 T>C D1597D rs1032474
  exon 27 c.5004 C>A I1668I rs17219005
  exon 31 c.5556 A>G G1853G Not described
  exon 34 c.5859 T>C V1953V rs4741426
        Note: no sequence variants were identified in CER1 and the A1212S alteration in FREM1 is present in 28% of controls (Coriell
        Collection).
Molecular Vision 2012; 18:1301-1311 <http://www.molvis.org/molvis/v18/a137> © 2012 Molecular Vision
1307regulatory  mutations  3′  to  PAX6  causing  aniridia  and
demonstrated  to  be  functionally  relevant  by  murine
transgenesis  rescue  experiments  [40,41].  In  an  attempt  to
define  such  elements,  seven  regions  conserved  across
vertebrates were sequenced, identifying a homozygous T>C
base  pair  substitution  (ECR-7)  that  segregated  with  the
phenotype. Bioinformatics analysis for regulatory elements
using  the  VISTA  Enhancer  Browser  online  database  [42]
yielded no tissue specific enhancers for this region (data not
shown). The most likely explanation is that this variant is in
linkage disequilibrium with the true mutation, and it should
be  noted  that  sequence  conservation  is  not  necessarily  a
criteria  of  all  regulatory  elements  [43].  Future  research
directions to support the relevancy of the identified 330 kb
IBD region could include assaying FREM1 expression from
mRNA isolated from skin fibroblasts of MOTA probands,
relative  to  a  housekeeping  gene  and  control  samples.  In
parallel,  next  generation  sequencing  of  the  330  kb  IBD
interval is increasingly feasible. It is interesting to note that
the transcription factor delta-Np63 has been shown to control
expression of members of the Fras/Frem gene family and
displays  enhancer  activity  in  the  murine  nose,  eyelids,
genitals, and digits [44,45], the tissue domains affected in FS,
BNAR, and MOTA.
In summary, this study extends FREM1 heterogeneity in
MOTA syndrome of First Nations ancestry. Homozygosity
mapping defined one 330 kb IBD region on chromosome
9p22.3 comprising 152 SNPs in 4 probands. Sequencing the
genes in or adjacent to this interval (FREM1, CER1, and
ZDHHC21)  revealed  no  disease-causing  mutations.
Accordingly,  we  infer  that  a  variant  within  this  region  is
responsible for MOTA syndrome, and suggest that future
studies are indicated to define the causative mutation and by
facilitating genetic counselling, reduce the high prevalence of
MOTA syndrome in these isolated populations.
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1310Appendix 1. Primers used to amplify CER1 and ZDHHC21.
To access the data, click or select the words “Appendix
1.” This will initiate the download of a compressed (pdf)
archive that contains the file.
Appendix 2. Primers used to amplify ECRs.
To access the data, click or select the words “Appendix
2.” This will initiate the download of a compressed (pdf)
archive that contains the file.
Appendix 3. Erroneous SNPs identified.
GenomeStudio’s heritability report algorithm was used
to identify potentially discrepant parent-child relationships
and  reveal  non-Mendelian  genotyping  errors.  Erroneous
SNPs  were  removed  before  homozygosity  analysis  with
PLINK.  More  than  99.9%  of  SNPs  are  inherited  in  a
Mendelian  manner  from  unaffected  mothers  to  probands
verifying correct parent child relationship. To access the data,
click or select the words “Appendix 3.” This will initiate the
download of a compressed (pdf) archive that contains the file.
Appendix 4. Percentage genome homozygosity.
Percentage homozygosity was derived from the ratio of
the total length of all autosomal homozygous regions, divided
by the length of all autosomes (2,867 Mb). To access the data,
click or select the words “Appendix 4.” This will initiate the
download of a compressed (pdf) archive that contains the file.
Appendix 5. A homozygous point mutation within ECR-7 segregates with
MOTA.
Electropherograms of a point mutation found to segregate
with the disease are shown for the four probands and the
unaffected  parents  in  ECR-7,  a  region  identified  by  ECR
Browser to be conserved from human, chimpanzee, rhesus
macaque, cow, opossum, rat, mouse, chicken and frog, but not
in puffer fish or zebrafish. Probands are homozygous C/C
while unaffected parents are C/T. The genomic reference used
to compare sequence is T/T in this position. To access the data,
click or select the words “Appendix 5.” This will initiate the
download of a compressed (pdf) archive that contains the file.
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